Biopharma data infrastructure and analytics for drug discovery
Excelra builds data and analytics infrastructure for biopharma R&D, combining domain expertise in drug discovery with engineering. The tech stack (Python, SQL, Databricks, AWS, Oracle) and active projects (ELN/LIMS deployment, biomarker analysis, lab workflow automation) show a company focused on operationalizing messy research data. Internal pain points around compliance-optimized data models and ELN-to-instrument integration signal they're solving integration and standardization problems their customers face.
Excelra serves pharmaceutical and biotech companies with data curation, bioinformatics, and analytics services spanning early-stage discovery through clinical development. The company operates a 501–1,000-person team headquartered in New Jersey, founded in 2016. Core offerings include ELN/LIMS configuration, biomarker discovery workflows, clinical data curation, and lab process automation—all built on a foundation of Python, Databricks, and cloud infrastructure (AWS, Oracle). Projects range from statistical modeling of biomarkers to automated laboratory workflows, with hiring concentrated in engineering and research roles across the U.S., India, Bulgaria, and Belgium.
Excelra uses Python, SQL, Databricks, AWS, Oracle, SQL Server, MongoDB, and .NET. The stack reflects both analytics (Databricks, Python) and enterprise backend infrastructure (Oracle, SQL Server, .NET).
Active projects include ELN/LIMS deployment, biomarker statistical analysis, lab workflow automation, and scientific workflow design. The work spans data infrastructure and research automation for drug discovery.
Other companies in the same industry, closest in size